Ralf Lutterbüse

1.3k total citations
13 papers, 1.0k citations indexed

About

Ralf Lutterbüse is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Ralf Lutterbüse has authored 13 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Ralf Lutterbüse's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (5 papers) and CAR-T cell therapy research (5 papers). Ralf Lutterbüse is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (5 papers) and CAR-T cell therapy research (5 papers). Ralf Lutterbüse collaborates with scholars based in Germany. Ralf Lutterbüse's co-authors include Peter Kufer, Patrick A. Baeuerle, Gert Riethmüller, Ralf C. Bargou, Florian Zettl, Anja Löffler, Peter T. Daniel, Jan M. Schwenkenbecher, Bernd Schlereth and Klaus Brischwein and has published in prestigious journals such as Blood, The Journal of Immunology and Trends in biotechnology.

In The Last Decade

Ralf Lutterbüse

13 papers receiving 961 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralf Lutterbüse Germany 11 681 580 447 304 102 13 1.0k
Grit Lorenczewski Germany 13 746 1.1× 611 1.1× 441 1.0× 269 0.9× 79 0.8× 17 995
Bernd Schlereth Germany 14 994 1.5× 832 1.4× 622 1.4× 432 1.4× 83 0.8× 23 1.4k
Klaus Brischwein Germany 17 1.1k 1.6× 728 1.3× 582 1.3× 451 1.5× 123 1.2× 21 1.5k
Florian Zettl Germany 9 612 0.9× 317 0.5× 300 0.7× 159 0.5× 259 2.5× 12 807
Margit Schmidt Germany 7 715 1.0× 427 0.7× 384 0.9× 232 0.8× 211 2.1× 13 1.0k
Maria-Elisabeth Goebeler Germany 13 803 1.2× 288 0.5× 438 1.0× 268 0.9× 113 1.1× 27 1.1k
Erik Pong United States 16 358 0.5× 617 1.1× 484 1.1× 433 1.4× 141 1.4× 24 1.1k
Tobias Raum Germany 19 1.0k 1.5× 635 1.1× 716 1.6× 471 1.5× 40 0.4× 35 1.5k
Birgit C. Schultes United States 19 334 0.5× 405 0.7× 558 1.2× 393 1.3× 161 1.6× 53 1.1k
Roman Kischel Germany 20 1.2k 1.8× 603 1.0× 819 1.8× 513 1.7× 110 1.1× 45 1.7k

Countries citing papers authored by Ralf Lutterbüse

Since Specialization
Citations

This map shows the geographic impact of Ralf Lutterbüse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Lutterbüse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Lutterbüse more than expected).

Fields of papers citing papers by Ralf Lutterbüse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Lutterbüse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Lutterbüse. The network helps show where Ralf Lutterbüse may publish in the future.

Co-authorship network of co-authors of Ralf Lutterbüse

This figure shows the co-authorship network connecting the top 25 collaborators of Ralf Lutterbüse. A scholar is included among the top collaborators of Ralf Lutterbüse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf Lutterbüse. Ralf Lutterbüse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Haas, Cornelia, Klaus Brischwein, Patrick Hoffmann, et al.. (2009). Mode of cytotoxic action of T cell-engaging BiTE antibody MT110. Immunobiology. 214(6). 441–453. 144 indexed citations
2.
Klinger, Matthias, Peter Kufer, Ralf Lutterbüse, et al.. (2006). T Cell Responses during Long-Term Continuous Infusion of MT103 (MEDI-538; Anti-CD19 BiTE) in Patients with Relapsed B-NHL: Data from Dose-Escalation Study MT103-104.. Blood. 108(11). 2725–2725. 4 indexed citations
3.
Schlereth, Bernd, Petra Kleindienst, Iduna Fichtner, et al.. (2005). Potent inhibition of local and disseminated tumor growth in immunocompetent mouse models by a bispecific antibody construct specific for Murine CD3. Cancer Immunology Immunotherapy. 55(7). 785–796. 44 indexed citations
4.
Mende, Ines, Patrick Hoffmann, Andreas Wolf, et al.. (2005). Highly efficient antigen targeting to M-DC8+ dendritic cells via FcγRIII/CD16-specific antibody conjugates. International Immunology. 17(5). 539–547. 15 indexed citations
5.
Kufer, Peter, Ralf Lutterbüse, & Patrick A. Baeuerle. (2004). A revival of bispecific antibodies. Trends in biotechnology. 22(5). 238–244. 111 indexed citations
6.
Kufer, Peter, Ralf Lutterbüse, & Patrick A. Baeuerle. (2004). The promise of bispecific antibodies.. PubMed. 4(23). 325–32. 2 indexed citations
7.
Dreier, Torsten, Patrick A. Baeuerle, Iduna Fichtner, et al.. (2003). T Cell Costimulus-Independent and Very Efficacious Inhibition of Tumor Growth in Mice Bearing Subcutaneous or Leukemic Human B Cell Lymphoma Xenografts by a CD19-/CD3- Bispecific Single-Chain Antibody Construct. The Journal of Immunology. 170(8). 4397–4402. 155 indexed citations
8.
Baeuerle, Patrick A., Peter Kufer, & Ralf Lutterbüse. (2003). Bispecific antibodies for polyclonal T-cell engagement.. PubMed. 5(4). 413–9. 42 indexed citations
9.
Kufer, Peter, Alfred Zippelius, Ralf Lutterbüse, et al.. (2002). Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.. PubMed. 62(1). 251–61. 64 indexed citations
10.
Kufer, Peter, et al.. (2001). Minimal costimulatory requirements for T cell priming and TH1 differentiation: activation of naive human T lymphocytes by tumor cells armed with bifunctional antibody constructs.. PubMed. 1. 10–10. 28 indexed citations
11.
Zippelius, Alfred, Ralf Lutterbüse, Gert Riethmüller, & Klaus Pantel. (2000). Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells.. PubMed. 6(7). 2741–50. 26 indexed citations
12.
Löffler, Anja, Peter Kufer, Ralf Lutterbüse, et al.. (2000). A recombinant bispecific single-chain antibody, CD19 × CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes. Blood. 95(6). 2098–2103. 357 indexed citations
13.
Kufer, Peter, Matthias Mack, Rudolf Gruber, et al.. (1997). Construction and biological activity of a recombinant bispecific single-chain antibody designed for therapy of minimal residual colorectal cancer. Cancer Immunology Immunotherapy. 45(3-4). 193–197. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026